digestive organs of both human fetus and adult, with a new monoclonal antibody (MAb) against M-PLA2, was investigated semiquantitatively. The immunoreactivity was distributed similarly in the adult and fetal epithelium of the esophagus, duodenum, and small intestine, and in the acinar, islet, and duct cells of the pancreas. The epithelium of adult gallbladder was immunoreactive. Paneth cells, especially the secretory apparatus, were strongly immunoreactive. Hepatic Kiipffer cells and macrophages of the adult spleen were also immunoreactive. These results suggest that these cells contain secretory-type Group I1 PLAz, which may be involved in host defensive mechanisms, such as phagocytosis in hu-Recently, a murine monoclonal antibody (MAb) against human M-PLA2 was developed (6). In the present study, MAb against human M-PLA2 was used to hmunohistochemically analyze the dis-Correspondence to: Michio Ogawa, Kumamoto Univ. Medical  School, 1-1-1 Honjo, Kumamoto 860, Japan. Literature Cited 1. Vadas P, Pruzanski W. Biology of disease: role of secretory phospholipase Az in the pathobiology of disease. Lab Invest 1986;55:391 2. Heinrikson RI., Krueger ET, Keim PS. Amino acid sequence of phospholipase A2-a from the venom of Crotalus adamanteus: a new classification of phospholipase A2 based upon structural determinants. J Biol Chem 1977;212:4913 3. Tojo H, Ono T, Kuramitsu S, Kagamiyama H, Okamoto M. A phos-
Introduction
Phospholipase A2 (PLA2) is a lipolytic enzyme which catalyzes the specific hydrolysis of a fatty acyl ester bond at the m -2 position of 3-glycerophospholipids (1). Recent studies have demonstrated that cellular calcium-dependent PLA2 of mammalian origin can be classified into at least two types according to distinct characteristics of its primary structure (2): pancreatic-type PLA2 (Group I PLA2) and viperid/crotalid-type PLA2 [Group I1 PLA2 or membrane-associated PLAz (M-PLA2) (3,4)]. The latter has also been identified in intra-articular fluid ( 5 ) .
Group I1 PLAz is hypothesized to be a regulatory factor in several metabolic pathways. Knowledge of the tissue and cellular distributions of this enzyme would assist in clarifying its biological function. However, the distribution of this enzyme in human organs has not been investigated.
man digestive organs. In the adult colon, the immunoreactivity was observed only in the ascending colon and was not found in the transverse, descending, sigmoid, or rectal colon. The immunoreactivity was not found in fetal colon.
Similarly, immunoreactivity was found in hepatocytes and Kiipffer cells of adult liver but not in fetal liver. By contrast, strong hunoreactivity was observed in the epithelium of the fetal stomach but not in adult stomach except in gastric neck cells. This suggests that the expression of M-PLA2 may be related to cell differentiation in particular organs. tribution of M-PLA2 in human fetal and adult digestive organs including the esophagus, stomach, duodenum, small intestine, colon, rectum, liver, gallbladder, pancreas, and spleen.
Materials and Methods
Tissue Samples. Normal adult tissues were obtained at autopsy from three patients (Case 1, 64 years, male, lung cancer and bronchitis; Case 2 . 6 9 years, female, bronchopneumonia; and Case 3, 75 years, male, laryngeal cancer and pneumonia) and surgical biopsy specimens were obtained from resections for neoplasms of adjacent organs. These biopsy specimens were obtained from one patient with esophageal cancer (65 years, male), seven with gastric cancer (age range 53-81 years, six males and one female), one with leiomyosarcoma of small intestine (39 years, female), nine with colon cancer (age range 56-73 years, four males and five females), and five with pancreatic cancer (age range 51-78 years, two males and three females). All tissues of the liver, gallbladder, and spleen used in this study were from autopsy specimens. The tissues studied were the esophagus, stomach, duodenum, jejunum, ileum, ascending colon, transverse colon, descending colon, sigmoid colon, rectum, liver, gallbladder, pancreas, and spleen. Adult digestive organs from at least three patients were studied. Fetal tissues were obtained at 23 and 25 weeks of gestation from necropsy specimens and consisted of the esophagus, stomach, small intestine, colon, liver, pancreas, and spleen.
Each specimen was fixed in 20% buffered formaldehyde and embed- 
Results

D&dution of M-PLA2 in Fetal a d Ad& Tusnes
The or spleen. By contrast, strong immunoreactivity was observed in fetal but not adult gastric mucosa. There was no significant difference of the immunoreactivity between autopsy and surgical biopsy specimens and between sexes examined in the present study. No immunoreactivity was found in the methodologic and specificity control reactions.
Esophagus. The stratified epithelium of the esophagus was im-munoreactive for M-PLA2. Strong immunoreactivity was particularly evident in the stratum corneum and stratum spinosum. In the stratum basale, few immunoreactive cells were found. There were no immunoreactive cells in the esophageal glands (Figure 1 ). The intensity and pattern of staining in the fetus was similar to that seen in the adult.
Stomach. In the adult stomach there were no immunoreactive cells in either the normal epithelium or glands other than in the gastric neck cells (Figure 2 ). However, strong immunoreactivity was found in the epithelium and fundic glands of the fetus.
Duodenum. The epithelium of the duodenum ( Figure 3A) and Brunner's glands were immunoreactive in a Golgi pattem, and brush borders ( Figure 3B) showed strong immunoreactivity in a luminal surface pattern. Paneth cells ( Figure 3C) were particularly immunoreactive, which corresponded to the supranuclear secretory apparatus, and crypt cells were also immunoreactive in a Golgi pattern ( Figure 3C ). Small Intestine. In the adult, the epithelium of the jejunum and ileum was immunoreactive in a Golgi pattern. In the fetus, the epithelium of small intestine was also immunoreactive in a Golgi pattern. Brush borders and Paneth cells were strongly immunoreactive.
Colon and Rectum. The epithelium of the adult ascending colon was immunoreactive in a Golgi pattern ( Figure 4A ). By contrast, immunoreactivity was not found in the transverse colon, descending colon (Figure 4B) , sigmoid colon, or rectum of the adult.
There were no immunoreactive cells in the colon of the fetus.
Pancreas. Almost all acinar cells ( Figure 5A ) and some islet (Figure 5B) and duct cells ( Figure 5C ) were immunoreactive in a Golgi pattern in the adult. Immunoreactivity was also observed in the fetus, but the staining intensity was weaker than that seen in the adult.
Liver. Immunoreactivity was found in limited numbers of adult hepatocytes in a cytoplasmic granular pattern ( Figure 6A) , and a zonular distribution of immunoreactive hepatocytes in the lobule was observed. Kiipffer cells were also immunoreactive in a cytoplasmic granular pattern ( Figure 6B ). No immunoreactive cells were observed in fetal liver.
Spleen. Adult macrophages were immunoreactive for M-PLA2 in a cytoplasmic granular pattern, whereas lymphocytes were devoid of immunoreactivity. In fetal spleen, no immunoreactivity was observed.
Gallbladder. In the adult gallbladder, epithelium was immunoreactive in a Golgi pattern. Fetal gallbladder was not available for study.
Discussion
Membrane-associated-type Group I1 PLA2 is hypothesized to regulate cellular phospholipid metabolism and release of prostaglandin (PG) precursors (10). Secretory type Group I1 PLA2 is also secreted into intra-articular fluid ( 5 ) , and a PLA2 in rheumatoid arthritis synovial fluid has been partially sequenced (11). However, the biological function of this form is not clear. Recently, the com-plete primary structure of human membrane-associated PLA2 (Group I1 PLA2) purified from a human spleen membrane fraction has been determined. The primary structure of secretory type human Group I1 PLAz has been reported and was confirmed to be identical to the primary structure of membrane-associated Group I1 PLAz (12).
In the present study, M-PLA2 was observed to be widely distributed throughout various digestive organs and cell types in humans. In the adult, immunoreactivity for M-PLA2 was demonstrated in the epithelium of the esophagus, duodenum, small intestine, ascending colon and gall bladder, gastric neck cells, acinar, islet, and duct cells of pancreas, hepatocytes and Kiipffer cells of liver, and macrophages of spleen. The secretory apparatus of Paneth cells in the duodenum and small intestine showed strong immunoreactivity for M-PLA2. Paneth cells are recognized to regulate intestinal flora through phagocytosis (13, 14) and are involved in the secretion of lysozyme (15). The immunoreactivity found in the secretory apparatus of Paneth cells suggests that the M-PLA2 recognized by this MAb is secretory-type Group I1 PLA2. The expression of M-PLA2 in Paneth cells, Kiipffer cells, and macrophages suggests that human M-PLA2 plays an essential role in extramucosal immune defense mechanisms.
Some differences in the presence of this enzyme were found between the fetus and the adult. M-PLA2 immunoreactivity was observed in the ascending colon of the adult but was not found in the fetal colon. Immunoreactivity was also found in adult hepatocytes, Kiipffer cells, and spleen macrophages but not in corresponding fetal tissues. By contrast, strong immunoreactivity was observed in the epithelium of the fetal but not the adult stomach. In the adult stomach, M-PLA2 was retained only in gastric neck cells, which are known to be the proliferating cells of the gastric mucosa. In a separate investigation, we observed strong immunoreactivity for M-PLA2 in the regenerating cell zone that develops subsequent to mucosal damage, and in intestinal metaplasia of crypt cells in the stomach. Furthermore, abundant expression of M-PLA2 was observed in poorly differentiated adenocarcinoma tissues, particularly in invasive gastric cancer (data not shown). These observations suggest that the expression of M-PLA2 is related to cell growth andlor differentiation.
The present study revealed that M-PLA2 immunoreactivity is distributed throughout digestive organs. The distribution and intracellular localization of M-PLA2 in these organs suggests that M-PLA2 may have functions other than regulation of intracellular metabolism.
